Abstract
1 The potency and selectivity of 5-(1-hydroxy-2-isopropylamino)butyl-8-hydroxy carbostyril hydrochloride hemihydrate (OPC-2009), a new β2-adrenoceptor stimulant, was compared with those of isoprenaline, trimetoquinol and salbutamol by the use of blood-perfused tracheal preparations in situ and of blood-perfused papillary muscle preparations of the dog. All drugs were injected intra-arterially.
2 All the four drugs decreased tracheal intraluminal pressure (tracheal relaxation) and increased tracheal blood flow in a dose-dependent manner. The four drugs produced a dose-dependent increase in developed tension of papillary muscles. In both preparations the duration of action of isoprenaline and salbutamol was short, whereas that of OPC-2009 and trimetoquinol was long. These effects were antagonized by propranolol.
3 Dose-response curves to the four drugs for tracheal relaxation were almost parallel. OPC-2009 was 2.4 times more potent, and trimetoquinol and salbutamol were 2.2 and 6.2 times less potent than isoprenaline in causing tracheal relaxation.
4 Dose-response curves to the four drugs for tracheal vasodilatation were also parallel. OPC-2009, trimetoquinol and salbutamol were 3.9, 6.7 and 23 times less potent than isoprenaline.
5 Slopes of the dose-response curves to the four drugs for increased developed tension were not parallel; that of OPC-2009 was the least steep, whereas that of isoprenaline was the steepest. Trimetoquinol, salbutamol and OPC-2009 were about 18, 570 and 2400 times less potent than isoprenaline.
6 Selectivity calculated from relative potencies indicate that OPC-2009 was about 6000 times, salbutamol about 92 times and trimetoquinol about 8.2 times more selective than isoprenaline for tracheal smooth muscle as compared to ventricular muscle.
7 The high potency and selectivity of OPC-2009 for tracheal smooth muscle and its long duration of action suggest its potential usefulness for treatment of bronchial asthma.
8 The present results are also compatible with the concept that β1-adrenoceptors in cardiac muscle and β2-adrenoceptors in tracheal and vascular smooth muscle can be distinguished. Furthermore, the results revealed that the β-adrenoceptors mediating tracheal relaxation and vasodilatation may also be different.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bowman W. C., Rodger I. W. Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat. Br J Pharmacol. 1972 Aug;45(4):574–583. doi: 10.1111/j.1476-5381.1972.tb08115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bristow M., Sherrod T. R., Green R. D. Analysis of beta receptor drug interactions in isolated rabbit atrium, aorta, stomach and trachea. J Pharmacol Exp Ther. 1970 Jan;171(1):52–61. [PubMed] [Google Scholar]
- Brittain R. T., Farmer J. B., Jack D., Martin L. E., Simpson W. T. Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature. 1968 Aug 24;219(5156):862–863. doi: 10.1038/219862a0. [DOI] [PubMed] [Google Scholar]
- Brittain R. T., Jack D., Ritchie A. C. Recent beta-adrenoreceptor stimulants. Adv Drug Res. 1970;5:197–253. [PubMed] [Google Scholar]
- Conway W. D., Minatoya H., Lands A. M., Shekosky J. M. Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog. J Pharm Sci. 1968 Jul;57(7):1135–1141. doi: 10.1002/jps.2600570710. [DOI] [PubMed] [Google Scholar]
- Cullum V. A., Farmer J. B., Jack D., Levy G. P. Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol. 1969 Jan;35(1):141–151. doi: 10.1111/j.1476-5381.1969.tb07975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dungan K. W., Cho Y. W., Gomoll A. W., Aviado D. M., Lish P. M. Pharmacologic potency and selectivity of a new bronchodilator agent: soterenol (MJ 1992). J Pharmacol Exp Ther. 1968 Dec;164(2):290–301. [PubMed] [Google Scholar]
- Endoh M., Hashimoto K. Pharmacological evidence of autonomic nerve activities in canine papillary muscle. Am J Physiol. 1970 May;218(5):1459–1463. doi: 10.1152/ajplegacy.1970.218.5.1459. [DOI] [PubMed] [Google Scholar]
- Farmer J. B., Kennedy I., Levy G. P., Marshall R. J. A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol. 1970 Jan;22(1):61–63. doi: 10.1111/j.2042-7158.1970.tb08388.x. [DOI] [PubMed] [Google Scholar]
- Giles R. E., Williams J. C., Finkel M. P. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol. J Pharmacol Exp Ther. 1973 Sep;186(3):472–481. [PubMed] [Google Scholar]
- Gryglewski R., Vane J. R. The inactivation of noradrenaline and isoprenaline in dogs. Br J Pharmacol. 1970 Jul;39(3):573–584. doi: 10.1111/j.1476-5381.1970.tb10365.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartley D., Jack D., Lunts L. H., Ritchie A. C. New class of selective stimulants of beta-adrenergic receptors. Nature. 1968 Aug 24;219(5156):861–862. doi: 10.1038/219861a0. [DOI] [PubMed] [Google Scholar]
- Himori N., Taira N. A method for recording smooth muscle and vascular responses of the blood-perfused dog trachea in situ. Br J Pharmacol. 1976 Mar;56(3):293–299. doi: 10.1111/j.1476-5381.1976.tb07641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iwasawa Y., Kiyomoto A. Studies on tetrahydroisoquinolines (THI). I. Bronchodilator activity and structure-activity relationship. Jpn J Pharmacol. 1967 Jun;17(2):143–152. doi: 10.1254/jjp.17.143. [DOI] [PubMed] [Google Scholar]
- Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
- Lands A. M., Luduena F. P., Buzzo H. J. Differentiation of receptors responsive to isoproterenol. Life Sci. 1967 Nov 1;6(21):2241–2249. doi: 10.1016/0024-3205(67)90031-8. [DOI] [PubMed] [Google Scholar]
- Morgan C. D., Sandler M., Davies D. S., Conolly M., Paterson J. W., Dollery C. T. The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J. 1969 Aug;114(1):8P–8P. doi: 10.1042/bj1140008pa. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSS S. B. IN VIVO INACTIVATION OF CATECHOLAMINES IN MICE. Acta Pharmacol Toxicol (Copenh) 1963;20:267–273. doi: 10.1111/j.1600-0773.1963.tb01744.x. [DOI] [PubMed] [Google Scholar]
- Sato M., Yamaguchi I., Kiyomoto A. Studies on tetradhydroisoquinolines (THI). II. Pharmacological action on the cardiovascular system. Jpn J Pharmacol. 1967 Jun;17(2):153–163. doi: 10.1254/jjp.17.153. [DOI] [PubMed] [Google Scholar]
- Wardell J. R., Colella D. F., Shetzline A., Fowler P. J. Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent. J Pharmacol Exp Ther. 1974 Apr;189(1):167–184. [PubMed] [Google Scholar]
- Wasserman M. A., Levy B. Cardiovascular and bronchomotor responses to selective beta adrenergic receptor agonists in the anesthetized dog. J Pharmacol Exp Ther. 1974 May;189(2):445–455. [PubMed] [Google Scholar]
- Yoshizaki S., Tanimura K., Tamada S., Yabuuchi Y., Nakagawa K. Sympathomimetic amines having a carbostyril nucleus. J Med Chem. 1976 Sep;19(9):1138–1142. doi: 10.1021/jm00231a011. [DOI] [PubMed] [Google Scholar]